Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Seminars in hematology (Print)

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0037-1963(03)70002-XPMID 12704587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The molecular pathology of Kaposi's sarcoma-associated herpesvirus.

  2002cited by this paper
• Epstein-Barr virus.

  2001cited by this paper
• The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus.

  2001cited by this paper
• Molecular virology of Kaposi's sarcoma-associated herpesvirus.

  2001cited by this paper
• EBNA-LP Associates with Cellular Proteins Including DNA-PK and HA95

  2001cited by this paper
• An Epstein-Barr-related herpesvirus from marmoset lymphomas.

  2001cited by this paper
• Role of Epstein-Barr virus in Burkitt's lymphoma.

  2001cited by this paper
• NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells.

  2000cited by this paper
• Epstein-Barr Virus Small RNAs Potentiate Tumorigenicity of Burkitt Lymphoma Cells Independently of an Effect on Apoptosis

  2000cited by this paper
• The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma–E2F pathway and with the oncogene Hras transforms primary rat cells

  2000cited by this paper
• Human Herpesvirus 8 LANA Interacts with Proteins of the mSin3 Corepressor Complex and Negatively Regulates Epstein-Barr Virus Gene Expression in Dually Infected PEL Cells

  2000cited by this paper
• Modulation of p27Kip1 levels by the cyclin encoded by Kaposi's sarcoma‐associated herpesvirus

  1999cited by this paper
• p53 inhibition by the LANA protein of KSHV protects against cell death

  1999cited by this paper
• Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus.

  1999cited by this paper
• Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma

  1999cited by this paper
• The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.

  1999cited by this paper
• Matrix Metalloproteinase 9 Expression Is Induced by Epstein-Barr Virus Latent Membrane Protein 1 C-Terminal Activation Regions 1 and 2

  1999cited by this paper
• The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors

  1999cited by this paper
• Sequence and Genomic Analysis of a Rhesus Macaque Rhadinovirus with Similarity to Kaposi’s Sarcoma-Associated Herpesvirus/Human Herpesvirus 8

  1999cited by this paper
• Degradation of p27Kip cdk inhibitor triggered by Kaposi's sarcoma virus cyclin–cdk6 complex

  1999cited by this paper
• The Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 Engages the Tumor Necrosis Factor Receptor-Associated Proteins TRADD and Receptor-Interacting Protein (RIP) but Does Not Induce Apoptosis or Require RIP for NF-κB Activation

  1999cited by this paper
• Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Activates the JNK Pathway through Its Extreme C Terminus via a Mechanism Involving TRADD and TRAF2

  1999cited by this paper
• Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.

  1999cited by this paper
• Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus

  1998cited by this paper
• Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.

  1998cited by this paper
• Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice.

  1998cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• Epstein-Barr Virus Contributes to the Malignant Phenotype and to Apoptosis Resistance in Burkitt’s Lymphoma Cell Line Akata

  1998cited by this paper
• Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis.

  1997cited by this paper
• Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins

  1997cited by this paper
• Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

  1997cited by this paper
• Epstein – Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors

  1997cited by this paper
• Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation

  1997cited by this paper
• Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species

  1997cited by this paper
• Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.

  1996cited by this paper
• Epstein-Barr virus and its replication

  1996cited by this paper
• Expression of Epstein‐Barr virus nuclear antigen‐1 induces B cell neoplasia in transgenic mice.

  1996cited by this paper
• The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa)

  1996cited by this paper
• Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

  1996cited by this paper
• Defective presentation of MHC class I‐restricted cytotoxic T‐cell epitopes in Burkitt's lymphoma cells

  1996cited by this paper
• Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1

  1995cited by this paper
• The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family.

  1995cited by this paper
• Notch takes a short cut

  1995cited by this paper
• Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator

  1995cited by this paper
• Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases.

  1995cited by this paper
• Signal transduction. Notch takes a short cut.

  1995cited by this paper
• Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.

  1994cited by this paper
• The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.

  1994cited by this paper
• Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV

  1994cited by this paper
• Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.

  1994cited by this paper
• Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state

  1994cited by this paper
• Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes

  1993cited by this paper
• The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro

  1993cited by this paper
• Epstein-Barr virus recombinants with specifically mutated BCRF1 genes

  1993cited by this paper
• Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

  1993cited by this paper
• Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation

  1993cited by this paper
• The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B.

  1992cited by this paper
• The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential

  1992cited by this paper
• Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes

  1992cited by this paper
• An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator

  1991cited by this paper
• EAP, a highly conserved cellular protein associated with Epstein‐Barr virus small RNAs (EBERs).

  1991cited by this paper
• Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.

  1991cited by this paper
• The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation

  1991cited by this paper
• Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.

  1991cited by this paper
• Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1

  1990cited by this paper
• Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

  1990cited by this paper
• Translational control by the Epstein-Barr virus small RNA EBER-1. Reversal of the double-stranded RNA-induced inhibition of protein synthesis in reticulocyte lysates.

  1990cited by this paper
• Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia.

  1990cited by this paper
• Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.

  1989cited by this paper
• Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes

  1989cited by this paper
• Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity

  1988cited by this paper
• Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

  1987cited by this paper
• Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization.

  1986cited by this paper
• An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

  1985cited by this paper
• Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells

  1985cited by this paper
• Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye

  1982cited by this paper
• Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus.

  1981cited by this paper
• VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

  1964cited by this paper

• Human herpes virus 8 antibodies in HIV-positive patients in Surabaya, Indonesia

  2020cites this paper
• DETECTION OF HUMAN HERPESVIRUS-8 ANTIGEN IN HIV-INFECTED PATIENTS IN EAST JAVA, INDONESIA

  2018cites this paper
• Cytokines and persistent viral infections.

  2016cites this paper
• Association of Interleukin-10 promoter polymorphisms with neurosyphilis.

  2015cites this paper
• Interleukin-10 production at the early stage of infection with foot-and-mouth disease virus related to the likelihood of persistent infection in cattle

  2015cites this paper
• Effect of high dose vitamin C on Epstein-Barr viral infection

  2014cites this paper
• Prospective analysis of the primary immune response during naturally acquired Epstein-Barr virus infection in humans

  2013cites this paper
• Pathogenetic Mechanisms of Hepatitis C Virus-Induced B-Cell Lymphomagenesis

  2012cites this paper
• Immune-Related Disorders and Extrahepatic Diseases in Chronic HCV Infection

  2012cites this paper
• Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.

  2012cites this paper
• HIV, EBV and KSHV: Viral cooperation in the pathogenesis of human malignancies

  2011cites this paper
• Function of monocytes in chronic HCV infection: Role for IL-10 and interferon

  2011cites this paper
• HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies.

  2011cites this paper
• Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections

  2011cites this paper
• Generation and Function of CD8 T Cell Memory to γ-Herpesviral Infection

  2010cites this paper
• Étude de l’infection lytique du Virus Epstein-Barr dans le développement de tumeurs post-greffe

  2010cites this paper
• Programmed death-1–induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection

  2010cites this paper
• Environmental and Genetic Factors Influence the Relationship Between Circulating IL‐10 and Obesity Phenotypes

  2010cites this paper
• KAPOSI'S SARCOMA AND MALIGNANT LYMPHOMAS IN TANZANIA DURING THE AIDS EPIDEMIC

  2009cites this paper
• Interleukin‐10‐secreting T cells define a suppressive subset within the HIV‐1‐specific T‐cell population

  2009cites this paper
• Pathogenetic mechanisms in B-cell lymphomagenesis

  2009cites this paper
• Interaction of Adenovirus E1A with the HHV8 Promoter of Latent Genes: E1A Proteins are Able to Activate the HHV-8 LANAp in MV3 Reporter Cells

  2008cites this paper
• Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections

  2008cites this paper
• IL‐10 and the resolution of infections

  2008influential citation
• Human herpesvirus 8-associated spinal cord lymphoma in an HIV-positive subject.

  2006cites this paper
• Resolution of a chronic viral infection after interleukin-10 receptor blockade

  2006cites this paper
• Apoptosis as a Pathogenic Mechanism of HIV-Associated Opportunistic Infections

  2005cites this paper
• AIDS and endemic Kaposi's sarcoma development : Comparison by histopathology, virology (HHV8/KSHV) and cytogenetics

  2005cites this paper
• Susceptibility of human herpesvirus 8 as well as other herpesviruses and their enzymes towards various chemotherapeutical agents

  2004cites this paper
• Is it now the time to update treatment protocols for lymphomas with new anti-virus systems?

  2004cites this paper